Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Uplizna. Always confirm against the full prescribing information.
100 interactions
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Inebilizumab.
Level 2 evidence
AstraZeneca COVID-19 Vaccine
The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Inebilizumab.
The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Inebilizumab.
The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Inebilizumab.
Level 2 evidence
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Inebilizumab.
Level 1 evidence
Abatacept
The risk or severity of infection can be increased when Abatacept is combined with Inebilizumab.
Level 1 evidence
Adalimumab
The risk or severity of infection can be increased when Adalimumab is combined with Inebilizumab.
Level 1 evidence
Aducanumab
The risk or severity of adverse effects can be increased when Aducanumab is combined with Inebilizumab.
Level 2 evidence
Alclometasone
The risk or severity of infection can be increased when Alclometasone is combined with Inebilizumab.
Level 1 evidence
Aldesleukin
The risk or severity of infection can be increased when Aldesleukin is combined with Inebilizumab.
Level 1 evidence
Alemtuzumab
The risk or severity of infection can be increased when Alemtuzumab is combined with Inebilizumab.
Level 1 evidence
Enter your NPI to unlock 4 major interactions for Uplizna
Uplizna (Inebilizumab) has 394 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Uplizna (Inebilizumab) has 12 major, 37 moderate, and 345 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Uplizna. Always confirm against the full prescribing information.